Cultural Thesis

Scan

Cultural Thesis

Scan symbols 7
BRBRCROXDPZHIMSLULUNKESBUX
Watchlists 1
@cultural-thesis
raw scan snapshot — prices as of scan date, not live 16 rows · screens, not recommendations ported fromresearch/classic/scans/2026-04-13-cultural-thesis.md

2026-04-14 Cultural Thesis Scan

Signal Reading
Overall 🔴 Consumer discretionary cultural names in structural breakdown — NKE and BRBR leading the carnage
Key insight The cultural arbitrage thesis is inverted — mass-market consumer brands are losing pricing power and cultural relevance simultaneously

This watchlist was built on the premise that cultural momentum leads stock price. The theory was: brands that are "having a cultural moment" (HIMS's GLP-1 adjacency, BRBR's protein obsession, CROX's ironic cool) would command premium multiples. The data says: not right now.

NKE is a catastrophe. RSI 24, -21.7% in 30 days, -34.1% in 3 months, -46% from 52wk high, death cross, below all three SMAs. The brand has cultural problems (athlete defections, China exposure) that no amount of marketing can fix quickly. BRBR (BellRing Brands) isn't far behind: -36% in 3 months, -81% from 52wk high, death cross.

The only bright spot is CROX (+26.9% in 30 days, RSI 73.2) and SBUX (+3.3% 7D, strong-up, golden cross). CROX has a death cross but the price action is recovering hard — this is either a genuine bottoming or a dead-cat bounce on a name that's been destroyed for 3 years. LULU is flatish but death cross confirmed and -52% from high.

The honest read: this watchlist is telling us that consumer brands that rode pandemic-era cultural tailwinds are mean-reverting brutally, and only the operational efficiency stories (SBUX turnaround) or the fashion-volatility plays (CROX bounce) are showing life. HIMS is the one to watch — down -32% in 3 months but GLP-1 biosimilar pipeline is real if the FDA follows through.

Cultural Thesis Price Table

Stock Price 7D 30D 3M RSI vs SMA200 Status Action
BRBR $15.11 -8.75% -19.1% -36.4% 38.2 -52.9% 🔴 Strong-down ❌ Don't Buy
HIMS $21.15 -3.5% -15.0% -32.5% 52.1 -45.5% 🔴 Death Cross 🔍 Watch
NKE $42.91 -3.0% -21.7% -34.1% 24 ↓ -34.2% 🔴 Strong-down ❌ Don't Buy
LULU $162.56 +5.6% +1.7% -20.0% 50.0 -12.9% 🔴 Strong-down 🔍 Watch
SBUX $97.48 +3.3% -0.4% +7.6% 57.9 +9.8% 🟢 Strong-up 🔒 Hold
CROX $100.22 +15.4% +26.9% +20.0% 73.2 ↑ +14.7% 🟡 Up ⚠️ Avoid Chase
DPZ $368.83 -3.0% -6.0% -9.0% 46.2 -11.6% 🔴 Strong-down 🔍 Watch

Action Matrix

Action Stocks Why
🔒 HOLD SBUX Only strong-up golden-cross name in the group — turnaround intact
🔍 WATCH HIMS, LULU, DPZ Beaten up but thesis potentially intact — need RSI + catalyst to confirm
⚠️ AVOID CHASE CROX RSI 73.2 on a dead-cat candidate — risky
❌ DON'T BUY NKE, BRBR Both in structural breakdown — NKE RSI 24, BRBR -81% from high

Key Discoveries

Discovery Implication
NKE RSI 24 approaching extreme oversold At some point this is a contrarian entry — but broken thesis, not yet
CROX +26.9% in 30 days despite death cross Fashion-volatility bounce or genuine reversal — unclear, don't chase
SBUX is the only golden-cross name in the watchlist Operational turnaround thesis separating from brand-trend names

Open Questions

  • NKE: Is RSI 24 approaching a capitulation entry, or is China exposure + tariff risk a structural impairment?
  • HIMS: FDA stance on GLP-1 biosimilars — the make-or-break catalyst
10 events
DateTypeEvent
Apr 26 ScanCultural Thesis Scan Apr 26 ScanConsumer Scan Apr 13 ScanConsumer Scan Apr 28 ScanCultural Thesis Scan Apr 10 UpdateConsumer Candidates Apr 10 ScanConsumer Scan Apr 3 UpdateConsumer Candidates Apr 3 ScanConsumer Scan Apr 26 UpdateConsumer Candidates Mar 31 ScanConsumer Scan

No direct external sources are attached to this read.